Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease

The American Journal of Cardiology
Anna TosoFrancesco Bellandi

Abstract

We investigated the efficacy of short-term high-dose atorvastatin in decreasing the risk of contrast-induced nephropathy (CIN) in patients with chronic kidney disease (CKD) subjected to coronary angiography and/or angioplasty. CIN occurs in up to 15% of patients with pre-existing CKD and affects clinical outcome. The protective effect of statin therapy against CIN is still controversial. A prospective, single-center study of 304 patients with baseline estimated creatinine clearance <60 ml/min were randomized to receive atorvastatin 80 mg/day or placebo for 48 hours before and 48 hours after contrast medium administration. All patients received intravenous saline hydration and oral N-acetylcysteine 1,200 mg 2 times/day. Iso-osmolar contrast medium was used. CIN was defined as an absolute increase of serum creatinine > or = 0.5 mg/dl within 5 days after the procedure. CIN occurred in 31 patients (10%), 16 (11%) in the placebo group and 15 (10%) in the atorvastatin group (p = 0.86). Mean increase in creatinine was not significantly different in the 2 groups (0.59 + or - 0.17 in placebo group vs 0.72 + or - 0.26 mg/dl in atorvastatin group, p = 0.31). Persistent kidney injury, defined as 1-month increase from baseline creatinine va...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Jul 20, 2000·The New England Journal of Medicine·M TepelW Zidek
Jul 11, 2002·Journal of the American College of Cardiology·Carlo BriguoriBruno Ricciardelli
Jul 31, 2003·The American Journal of Cardiology·Luis C L CorreiaJ Péricles Esteves
Feb 20, 2004·European Heart Journal·Carlo BriguoriBruno Ricciardelli
Nov 3, 2004·Journal of the American College of Cardiology·Micha MaederHans Rickli
Nov 5, 2004·Clinical Nephrology·N AttallahK Fisher
Aug 9, 2005·The American Journal of Medicine·Sanjaya KhanalMauro Moscucci
Apr 28, 2006·The New England Journal of Medicine·Jorge L GrossSandra P Silveiro
Sep 5, 2006·The American Journal of Cardiology·Peter A McCulloughUNKNOWN CIN Consensus Working Panel
Sep 5, 2006·The American Journal of Cardiology·Fulvio StaculUNKNOWN CIN Consensus Working Panel
Apr 12, 2008·Journal of the American College of Cardiology·Peter A McCullough
Jun 21, 2008·Journal of the American College of Cardiology·Charles R Harper, Terry A Jacobson
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group

❮ Previous
Next ❯

Citations

Sep 30, 2010·Nature Reviews. Nephrology·Andrew D CalvinAxel Pflueger
Jul 10, 2010·European Heart Journal·Luigi Marzio Biasucci, Italo Porto
Apr 11, 2014·BioMed Research International·Pattharawin Pattharanitima, Adis Tasanarong
May 9, 2014·BioMed Research International·Ulla Ludwig, Frieder Keller
Apr 8, 2014·Journal of Thrombosis and Thrombolysis·Lucia BarbieriGiuseppe De Luca
Oct 1, 2014·Radiología·C Ramírez RibellesJ Pamies Guilabert
Dec 15, 2012·The British Journal of Radiology·C S KwokY K Loke
Sep 20, 2011·International Journal of Cardiology·Hisato Takagi, Takuya Umemoto
Sep 29, 2011·The Canadian Journal of Cardiology·Bu-Chun ZhangYa-Wei Xu
Oct 3, 2014·BioMed Research International·Mariangela PeruzziGiuseppe Biondi-Zoccai
Feb 8, 2014·Renal Failure·Song Mao, Songming Huang
Sep 21, 2010·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·O SchoutenD Poldermans
May 24, 2014·The American Journal of Medicine·Sumeet GandhiMichael E Farkouh
Jan 28, 2014·Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses·Hiba DeekPatricia M Davidson
May 20, 2015·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Keith ThompsonSomjot S Brar
Sep 19, 2012·Vascular Pharmacology·Nicoletta RondaEnrico Fiaccadori
Oct 5, 2010·Cardiology Research and Practice·Sana ShoukatSajid H Dhakam
Aug 28, 2016·British Journal of Anaesthesia·G T C WongM G Irwin
Apr 7, 2017·Seminars in Dialysis·Jehan Z BahrainwalaMichael R Rudnick
Mar 10, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·Monica A MuñozRobert L Talbert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.